CAC
COCHW icon

Cowen and Company’s Envoy Medical Warrant COCHW Stock Holding History

Cowen and Company’s Portfolio COCHW Stock Details COCHW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-50,000
Closed -$5.33K – 637
2024
Q1 		$5.33K Sell
50,000
-67,349
-57% -$4.51K ﹤0.01% 565
2023
Q4 		$2.35K Buy
+117,349
New +$3.17K ﹤0.01% 514
2023
Q2 		– Sell
-39,240
Closed -$1.48K – 593
2023
Q1 		$1.48K Sell
39,240
-8,807
-18% -$495 ﹤0.01% 543
2022
Q4 		$1.82K Sell
48,047
-18,619
-28% -$883 ﹤0.01% 581
2022
Q3 		$4K Buy
+66,666
New +$6.03K ﹤0.01% 533
2021
Q4 		– Sell
-49,997
Closed -$32K – 660
2021
Q3 		$32K Buy
+49,997
New +$40.6K ﹤0.01% 431

Other funds holding COCHW

AC
Athos Capital Hong Kong $324M AUM 16.62% 1-Year Est. Return
AC
Aristeia Capital Greenwich, Connecticut $4.82B AUM 24.91% 1-Year Est. Return
Walleye Capital
Walleye Capital New York $28B AUM 44.22% 1-Year Est. Return
Walleye Trading
Walleye Trading New York $87.6B AUM 68.17% 1-Year Est. Return
Man Group
Man Group London, United Kingdom $55.1B AUM 24.23% 1-Year Est. Return
EAM
Exos Asset Management New York $2.32K AUM 108.13% 1-Year Est. Return
CS
Clear Street New York $24.6B AUM 56.25% 1-Year Est. Return
PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.02% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
BCL
Bracebridge Capital LLC Boston, Massachusetts $3.73B AUM 33.02% 1-Year Est. Return

Cowen and Company's COCHW Position: Q2 2024 in Review

Cowen and Company sold out of Envoy Medical Warrant (COCHW) in Q2 2024, closing a stake of 50,000 shares — an estimated $5.33K sold.

Cowen and Company first reported a position in COCHW in Q3 2021 and held it in 6 quarters. The position peaked at $32K in Q3 2021. 45 funds tracked by Wall St. Rank hold COCHW as of Q2 2024.

  • Cowen and Company reported no remaining Envoy Medical Warrant position as of Q2 2024 after selling out during the quarter.
  • Cowen and Company sold 50,000 Envoy Medical Warrant shares in Q2 2024, an estimated $5.33K.
  • Cowen and Company first reported a position in Envoy Medical Warrant in Q3 2021 and held it in 6 quarters.
  • Cowen and Company's Envoy Medical Warrant position peaked at $32K in Q3 2021.
  • 45 funds tracked by Wall St. Rank held Envoy Medical Warrant as of Q2 2024.

Based on Cowen and Company's 13F filing for Q2 2024, filed 7 Aug 2024.